socalTECH

NOVEMBER 14, 2013

Monrovia, California-based Xencor has set the initial offering price for its IPO, saying in a filing Thursday morning that it will offer up 10,700,000 shares of its common stock at $7.00 The company plans to trade on the NASDAQ Global Market as XNCR. The company develops biopharmaceuticals technology. and $16.00

Pricing 157

Pricing Monrovia Acquisition Marketing 157

socalTECH

DECEMBER 3, 2013

Monrovia-based biopharmaceuticals developer Xencor said this morning that it has priced its IPO, at $5.50 per share, and will start trading today on the NASDAQ Global Market as XNCR. Xencor sold 12,730,000 shares of its common stock in the IPO. READ MORE>>.

Pricing 138

Pricing Monrovia Acquisition Marketing 138

socalTECH

NOVEMBER 4, 2013

Monrovia, California-based Xencor , the biopharmaceuticals technology developer headed by Bassil Dahiyat, has set its IPO pricing range, saying today in a regulatory filing that it is expecting to price its IPO at between $14.00 The company is looking to trade as XNCR on the NASDAQ Global Market. and $16.00

Pricing 138

Pricing Monrovia Acquisition Marketing 138